Beyond Traditional Surgery: How Advanced Endoscopic Techniques are Revolutionizing Colorectal Treatments
"Explore the innovative world of endoscopic procedures that are transforming the landscape of colorectal lesion management, offering less invasive options and improved patient outcomes."
For years, traditional surgery has been the standard approach for removing complex colorectal lesions. While effective, surgery often comes with significant recovery times, potential complications, and a considerable impact on a patient's quality of life. But what if there were less invasive options that could achieve similar results with fewer drawbacks? Recent advancements in endoscopic techniques are making this a reality, offering new hope for patients facing colorectal lesion removal.
Endoscopic Submucosal Dissection (ESD) has emerged as a powerful tool for removing complex colorectal lesions. While ESD is highly effective, it can be technically challenging and associated with a higher incidence of adverse events. This has spurred the development of hybrid techniques like Knife-assisted resection (KAR).
This article delves into two innovative endoscopic techniques—Snare Tip Assisted Resection (STAR) and Full Thickness Resection Device (FTRD)—that are revolutionizing the treatment of colorectal lesions. We'll explore how these techniques work, their benefits, and the impact they're having on patient care.
The Growing Burden of Colorectal Lesions
Colorectal lesions remain a major clinical concern because they can progress to malignancy, and detection is heavily dependent on endoscopy. In one multicenter, retrospective study, 131 colorectal sessile lesions were enrolled and assessed by both expert and trainee endoscopists using magnified blue-light imaging combined with the JNET classification system to establish diagnostic predictions. Other researchers have explored predicting lesion severity using fecal hemoglobin levels, with the study's authors acknowledging that missing data on lesion stage and colonic location was a limitation inherent to its retrospective design. Cross-sectional and descriptive studies, such as a multicenter endoscopy study conducted among Sudanese patients, continue to map how colorectal lesions present across different populations and settings.
The Gold Standard and Its Blind Spots
Colonoscopy is widely regarded as the gold standard for colorectal cancer screening and diagnosis, and it has contributed to decreases in the incidence and mortality of colon cancer, yet it still carries a reported 21% rate of missed polyps. A range of other screening tests exist, each with its own advantages and disadvantages, which means no single method is without trade-offs. Endoscopic submucosal dissection (ESD) has emerged as a method of en-bloc resection of neoplastic colorectal lesions that is less invasive than surgical resection. Advanced endoscopic approaches have also gained experience in colon-sparing surgery for complex colorectal lesions, expanding treatment options beyond traditional resection.
From Classification to Clonal Origins
Understanding of colorectal lesions has evolved through increasingly refined classification, such as subclassifying serrated lesions in the lower gastrointestinal tract into hyperplastic polyps and serrated adenomas. Guidance from the U.S. Multi-Society Task Force on Colorectal Cancer synthesized high-quality studies to generate recommendations and, where such evidence was unavailable, relied on lower-quality evidence and expert opinion. More recently, analyses of early colorectal cancer lesions indicate that tumours may originate from several genetically distinct cell populations, challenging older assumptions about single-clone initiation. Population studies, such as cross-sectional screening of 162 first-degree relatives of patients with colorectal lesions, have also shaped how risk in families is assessed.
Snare Tip Assisted Resection (STAR): A Novel Technique
STAR is a novel approach developed to improve the outcomes of complex colorectal lesion removals. This technique involves using a snare tip to assist in the resection of lesions, particularly those that are difficult to remove with traditional methods. Here’s a closer look at how it works:
- Enhanced precision in lesion removal.
- Applicability to lesions with early malignancy.
- Use in recurrent or scarred lesions.
- Assistance in resecting polyps with flat components.
IEE, AI, and Resection Advances
Recent reviews report that image-enhanced endoscopy (IEE) is being studied both individually and in combination with artificial intelligence for colorectal lesion detection, referencing the latest clinical trial data to characterize each modality's effectiveness. In a multicenter, retrospective study, 131 colorectal sessile lesions were evaluated by expert and trainee endoscopists using magnified blue-light imaging with the JNET classification system to establish diagnostic predictions. Systematic reviews comparing endoscopic submucosal dissection (ESD) with endoscopic mucosal resection note that ESD of colorectal lesions is demanding and that a significant rate of non-curative procedures is expected. Meanwhile, updated recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer continue to guide when and how endoscopic removal of colorectal lesions should be performed.
When Endoscopy Falls Short
Despite advances, traditional white-light imaging has documented limitations in detecting colorectal lesions, particularly those with flat morphology or minimal color contrast, and colorectal cancer remains a leading cause of cancer-related mortality. Procedures can also fail: reports describe outcomes of large colorectal lesions subjected to prior failed resection or substantial manipulation, highlighting the role of routine examination of the post-resection defect with magnification to help ensure complete removal of visible tissue. Complications remain a real concern, as illustrated by a case of cytomegalovirus colitis that developed during prolonged chemotherapy for metastatic colorectal cancer and led to colonic perforation requiring emergency surgery. The case underscores how immunocompromised patients, especially those on long-term steroids, may present with persistent diarrhea and progress to severe, surgery-requiring complications.
Weighing Endoscopic Techniques
Comparative research shows that underwater endoscopic mucosal resection (UEMR) is a valid alternative to conventional EMR (CEMR) for large nonpedunculated colorectal lesions, and one trial suggests it could be considered the first option for lesions between 20 and 30 mm because of its higher en bloc and R0 resection rates. Consistent with this, other reports indicate that UEMR achieves a high en bloc resection rate with a low adverse event rate and low recurrence, supporting it as an effective and safe alternative for treating colorectal lesions. Pathologic assessment itself introduces variability, since serrated lesions of the colon tend to have moderate interobserver variation among pathologists, likely due to the evolving definitions and significance of these lesions.
The Future of Colorectal Lesion Treatment
The advancements in endoscopic techniques like STAR and FTRD represent a significant leap forward in the treatment of colorectal lesions. By offering less invasive alternatives to traditional surgery, these techniques are improving patient outcomes, reducing recovery times, and enhancing the overall quality of life. As these methods continue to evolve, they promise to play an increasingly important role in the management of complex colorectal conditions, providing hope and better options for patients worldwide.
Matching Technique to Lesion Size
Expert commentary converges on size-based treatment strategies, noting that large colorectal lesions of at least 3 cm present a significant therapeutic challenge because of their potential for malignancy and the technical difficulties they pose. Research analyzing lesions by morphology, size, location, and histology found that lesions under 20 mm were resected en bloc, whereas lesions of 20 mm or larger were removed by piecemeal EMR (p-EMR), with adverse events and recurrence assessed for both approaches. This reflects a broader synthesis in which technique selection balances en-bloc resection goals against the technical demands and risks of larger lesions.
AI, Microbiome, and Clonal Biology
Artificial intelligence technologies for the detection of colorectal lesions have been described by investigators with the emphatic framing that 'the future is now,' pointing to their growing role in everyday endoscopic practice. Research on the gut microbiome associates it with preexisting colorectal lesions as well as the future development of lesions, and presenters at UEG Week suggested that including microbiome biomarkers may improve noninvasive tests for colorectal cancer. On the biology side, findings that colorectal lesions arise from the convergence of distinct mutant clones are reshaping understanding of lesion origin and could influence future prevention and surveillance strategies.
Operator Skill and System Capacity
Detection quality depends heavily on system-level factors, including the skills of the endoscopist, efficient colon cleansing techniques, and the duration of the procedure, especially during scope withdrawal, all of which greatly impact the detection of different lesions, particularly serrated ones in the cecum or ascending colon. Capacity for advanced procedures is also expanding, with one retrospective series of 15 challenging lesions finding that outpatient colorectal ESD was feasible, though the authors emphasized investigating safety, en bloc resection rates, and complication rates. ESD is described as particularly useful for very complex lesions—such as those that are scarred or stuck from a previous intervention—that are actually small but difficult to remove by conventional snare polypectomy, making it a valuable tool down to the colonic lining.
Improving Detection at the Bedside
Real-world evidence is emerging on how artificial intelligence-assisted colonoscopy changes outcomes in practice, with study objectives including comparing colorectal adenoma detection rate (ADR) between AI-assisted and conventional groups, with a particular focus on adenomatous lesions. These investigations also assess the diagnostic agreement between lesions detected by AI and histopathology. Such work directly measures whether advanced technology translates into better detection and more reliable characterization of the lesions that matter most to patients.